VOYA Investment Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $644K | Sell |
28,506
-632
| -2% | -$14K | ﹤0.01% | 1626 |
|
|
2025
Q4 | $754K | Buy |
29,138
+9,295
| +47% | +$221K | ﹤0.01% | 1583 |
|
|
2025
Q3 | $511K | Buy |
19,843
+7,241
| +57% | +$178K | ﹤0.01% | 1754 |
|
|
2025
Q2 | $301K | Buy |
12,602
+134
| +1% | +$3.38K | ﹤0.01% | 2145 |
|
|
2025
Q1 | $310K | Sell |
12,468
-1,480
| -11% | -$35.4K | ﹤0.01% | 2104 |
|
|
2024
Q4 | $263K | Sell |
13,948
-29,901
| -68% | -$525K | ﹤0.01% | 2265 |
|
|
2024
Q3 | $660K | Buy |
43,849
+6,962
| +19% | +$119K | ﹤0.01% | 1849 |
|
|
2024
Q2 | $1.06M | Sell |
36,887
-108
| -0.3% | -$3.07K | ﹤0.01% | 1600 |
|
|
2024
Q1 | $1.08M | Buy |
36,995
+3,119
| +9% | +$95.8K | ﹤0.01% | 1598 |
|
|
2023
Q4 | $1.14M | Buy |
33,876
+7,669
| +29% | +$224K | ﹤0.01% | 1617 |
|
|
2023
Q3 | $804K | Buy |
26,207
+196
| +0.8% | +$7.07K | ﹤0.01% | 1761 |
|
|
2023
Q2 | $1.04M | Buy |
26,011
+713
| +3% | +$29.5K | ﹤0.01% | 1643 |
|
|
2023
Q1 | $1.03M | Sell |
25,298
-187,303
| -88% | -$7.45M | ﹤0.01% | 1634 |
|
|
2022
Q4 | $8.21M | Sell |
212,601
-123,817
| -37% | -$6.02M | 0.01% | 790 |
|
|
2022
Q3 | $17.9M | Buy |
336,418
+239,059
| +246% | +$13.3M | 0.02% | 532 |
|
|
2022
Q2 | $5.68M | Sell |
97,359
-235,409
| -71% | -$15.4M | 0.01% | 694 |
|
|
2022
Q1 | $25.4M | Buy |
332,768
+304,266
| +1,068% | +$20.3M | 0.05% | 288 |
|
|
2021
Q4 | $1.72M | Sell |
28,502
-2,085
| -7% | -$115K | ﹤0.01% | 1236 |
|
|
2021
Q3 | $1.71M | Sell |
30,587
-23
| -0.1% | -$1.33K | ﹤0.01% | 1254 |
|
|
2021
Q2 | $1.86M | Sell |
30,610
-1,604
| -5% | -$102K | ﹤0.01% | 1246 |
|
|
2021
Q1 | $2.26M | Buy |
32,214
+485
| +2% | +$34.6K | ﹤0.01% | 1130 |
|
|
2020
Q4 | $1.9M | Buy |
31,729
+7,168
| +29% | +$420K | ﹤0.01% | 1173 |
|
|
2020
Q3 | $1.48M | Sell |
24,561
-210
| -0.8% | -$12.2K | ﹤0.01% | 1133 |
|
|
2020
Q2 | $1.3M | Sell |
24,771
-5,944
| -19% | -$248K | ﹤0.01% | 1170 |
|
|
2020
Q1 | $1.03M | Buy |
30,715
+11,000
| +56% | +$457K | ﹤0.01% | 1214 |
|
|
2019
Q4 | $893K | Buy |
19,715
+3,590
| +22% | +$152K | ﹤0.01% | 1517 |
|
|
2019
Q3 | $614K | Hold |
16,125
| – | – | ﹤0.01% | 1622 |
|
|
2019
Q2 | $701K | Sell |
16,125
-218
| -1% | -$9.26K | ﹤0.01% | 1562 |
|
|
2019
Q1 | $622K | Sell |
16,343
-367
| -2% | -$14.3K | ﹤0.01% | 1647 |
|
|
2018
Q4 | $719K | Buy |
16,710
+520
| +3% | +$24.3K | ﹤0.01% | 1501 |
|
|
2018
Q3 | $796K | Sell |
16,190
-175
| -1% | -$7.57K | ﹤0.01% | 1547 |
|
|
2018
Q2 | $524K | Sell |
16,365
-1,190
| -7% | -$41.1K | ﹤0.01% | 1795 |
|
|
2018
Q1 | $547K | Sell |
17,555
-570,892
| -97% | -$20.3M | ﹤0.01% | 1754 |
|
|
2017
Q4 | $26.9M | Sell |
588,447
-2,548
| -0.4% | -$101K | 0.06% | 343 |
|
|
2017
Q3 | $22.2M | Buy |
590,995
+125,156
| +27% | +$5.04M | 0.05% | 385 |
|
|
2017
Q2 | $22.2M | Buy |
465,839
+21,231
| +5% | +$985K | 0.05% | 370 |
|
|
2017
Q1 | $20.3M | Sell |
444,608
-95,033
| -18% | -$4.11M | 0.05% | 381 |
|
|
2016
Q4 | $17.4M | Buy |
539,641
+187,663
| +53% | +$6.26M | 0.04% | 409 |
|
|
2016
Q3 | $12K | Sell |
351,978
-13,750
| -4% | -$539K | 0.02% | 518 |
|
|
2016
Q2 | $12.3M | Buy |
365,728
+93,563
| +34% | +$4.6M | 0.03% | 499 |
|
|
2016
Q1 | $14.4M | Sell |
272,165
-50,350
| -16% | -$2.95M | 0.04% | 439 |
|
|
2015
Q4 | $24.8M | Sell |
322,515
-44,450
| -12% | -$2.52M | 0.06% | 288 |
|
|
2015
Q3 | $15.1M | Buy |
366,965
+77,725
| +27% | +$4.76M | 0.04% | 413 |
|
|
2015
Q2 | $20.5M | Buy |
289,240
+94,745
| +49% | +$7.46M | 0.05% | 343 |
|
|
2015
Q1 | $17.3M | Sell |
194,495
-94,009
| -33% | -$9.54M | 0.04% | 402 |
|
|
2014
Q4 | $25.6M | Buy |
288,504
+141,704
| +97% | +$13.4M | 0.06% | 305 |
|
|
2014
Q3 | $14.2M | Buy |
146,800
+32,170
| +28% | +$3.13M | 0.03% | 462 |
|
|
2014
Q2 | $10.5M | Buy |
114,630
+98,661
| +618% | +$7.51M | 0.02% | 591 |
|
|
2014
Q1 | $1.12M | Hold |
15,969
| – | – | ﹤0.01% | 1409 |
|
|
2013
Q4 | $918K | Hold |
15,969
| – | – | ﹤0.01% | 1516 |
|
|
2013
Q3 | $768K | Hold |
15,969
| – | – | ﹤0.01% | 1592 |
|
|
2013
Q2 | $463K | Buy |
+15,969
| New | +$462K | ﹤0.01% | 1898 |
|
Other funds holding PCRX
DPCM
VPM
VCM
VOYA Investment Management's PCRX Position: Q1 2026 in Review
VOYA Investment Management reduced its Pacira BioSciences (PCRX) stake by 2.2% in Q1 2026, selling an estimated $14K and leaving 28,506 shares worth $644K. The position accounts for ﹤0.01% of the portfolio, ranked #1626.
VOYA Investment Management first reported a position in PCRX in Q2 2013 and has held it in 52 quarters since. The position peaked at $26.9M in Q4 2017. 241 funds tracked by Wall St. Rank hold PCRX as of Q1 2026.
- VOYA Investment Management held 28,506 shares of Pacira BioSciences worth $644K as of Q1 2026.
- VOYA Investment Management sold 632 Pacira BioSciences shares in Q1 2026, an estimated $14K.
- Pacira BioSciences made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #1626 holding.
- VOYA Investment Management first reported a position in Pacira BioSciences in Q2 2013 and has held it in 52 quarters since.
- VOYA Investment Management's Pacira BioSciences position peaked at $26.9M in Q4 2017.
- 241 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2026.
Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.